BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
8.91
-0.19 (-2.09%)
At close: May 29, 2026, 4:00 PM EDT
8.95
+0.04 (0.45%)
After-hours: May 29, 2026, 7:52 PM EDT
BioCryst Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $22 → $21 | Buy | Maintains | $22 → $21 | +135.69% | May 7, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $25 → $28 | Buy | Maintains | $25 → $28 | +214.25% | May 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $32 | Buy | Maintains | $32 | +259.15% | May 7, 2026 |
| Needham | Needham | Buy Maintains $18 → $16 | Buy | Maintains | $18 → $16 | +79.57% | May 7, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $30 | Buy | Maintains | $30 | +236.70% | May 6, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $14 → $13 | Buy | Maintains | $14 → $13 | +45.90% | May 6, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Apr 16, 2026 |
| Evercore ISI | Evercore ISI | Buy Initiates $17 | Buy | Initiates | $17 | +90.80% | Feb 19, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.